All Relations between Schizophrenia and cannabis

Publication Sentence Publish Date Extraction Date Species
Michael Schaub, Kyra Fanghaenel, Charlotte Senn, Rudolf Stohle. Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers? Substance use & misuse. vol 43. issue 14. 2009-03-10. PMID:19085437. thus, schizophrenia patients treated with atypical neuroleptics do not differ in symptom patterns whether using or not using cannabis. 2009-03-10 2023-08-12 Not clear
Wolfram Kawohl, Wulf Rössle. [Cannabis and Schizophrenia: new findings in an old debate]. Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater. vol 22. issue 4. 2009-03-05. PMID:19080993. [cannabis and schizophrenia: new findings in an old debate]. 2009-03-05 2023-08-12 Not clear
J Stirling, E J Barkus, L Nabosi, S Irshad, G Roemer, B Schreudergoidheijt, S Lewi. Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort. Psychopathology. vol 41. issue 6. 2009-02-27. PMID:18787359. cannabis use has been identified as a possible risk factor for developing schizophrenia. 2009-02-27 2023-08-12 Not clear
Michael Schaub, Kyra Fanghaenel, Rudolf Stohle. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls. The Australian and New Zealand journal of psychiatry. vol 42. issue 12. 2009-02-27. PMID:19016094. reasons for cannabis use: patients with schizophrenia versus matched healthy controls. 2009-02-27 2023-08-12 Not clear
Michael Schaub, Kyra Fanghaenel, Rudolf Stohle. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls. The Australian and New Zealand journal of psychiatry. vol 42. issue 12. 2009-02-27. PMID:19016094. the aim of the present study was to compare self-reported reasons for cannabis use in patients with schizophrenia with those of matched healthy controls. 2009-02-27 2023-08-12 Not clear
C J Lake. A literature review to assess the reliability and validity of measures appropriate for use in research to evaluate the efficacy of a brief harm reduction strategy in reducing cannabis use among people with schizophrenia in acute inpatient settings. Journal of psychiatric and mental health nursing. vol 15. issue 9. 2009-02-13. PMID:18844804. a literature review to assess the reliability and validity of measures appropriate for use in research to evaluate the efficacy of a brief harm reduction strategy in reducing cannabis use among people with schizophrenia in acute inpatient settings. 2009-02-13 2023-08-12 Not clear
C J Lake. A literature review to assess the reliability and validity of measures appropriate for use in research to evaluate the efficacy of a brief harm reduction strategy in reducing cannabis use among people with schizophrenia in acute inpatient settings. Journal of psychiatric and mental health nursing. vol 15. issue 9. 2009-02-13. PMID:18844804. there is a growing body of evidence looking at the effects of cannabis use on those with schizophrenia with concerning results. 2009-02-13 2023-08-12 Not clear
C J Lake. A literature review to assess the reliability and validity of measures appropriate for use in research to evaluate the efficacy of a brief harm reduction strategy in reducing cannabis use among people with schizophrenia in acute inpatient settings. Journal of psychiatric and mental health nursing. vol 15. issue 9. 2009-02-13. PMID:18844804. this literature review assesses the self-report measures that have been reliability and validity tested in populations of people with schizophrenia who use cannabis and reports on their appropriateness for use in further research studies. 2009-02-13 2023-08-12 Not clear
Johannes Lodewikus Roos, Herman Walter Pretorius, Maria Karayiorgo. Clinical characteristics of an Afrikaner founder population recruited for a schizophrenia genetic study. Annals of the New York Academy of Sciences. vol 1151. 2009-02-10. PMID:19154519. approximately half of male schizophrenia patients and a quarter of female patients in the afrikaner schizophrenia database used or abused cannabis. 2009-02-10 2023-08-12 human
Cécile Henquet, Marta Di Forti, Paul Morrison, Rebecca Kuepper, Robin M Murra. Gene-environment interplay between cannabis and psychosis. Schizophrenia bulletin. vol 34. issue 6. 2009-02-03. PMID:18723841. cannabis use is considered a contributory cause of schizophrenia and psychotic illness. 2009-02-03 2023-08-12 Not clear
Cécile Henquet, Marta Di Forti, Paul Morrison, Rebecca Kuepper, Robin M Murra. Gene-environment interplay between cannabis and psychosis. Schizophrenia bulletin. vol 34. issue 6. 2009-02-03. PMID:18723841. this review will therefore consider the interplay between genes and exposure to cannabis in the development of psychotic symptoms and schizophrenia. 2009-02-03 2023-08-12 Not clear
Jim van Os, Bart Pf Rutten, Richie Poulto. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophrenia bulletin. vol 34. issue 6. 2009-02-03. PMID:18791076. concern is building about high rates of schizophrenia in large cities, and among immigrants, cannabis users, and traumatized individuals, some of which likely reflects the causal influence of environmental exposures. 2009-02-03 2023-08-12 Not clear
Stephane Potvin, Adham Mancini-Marie, Cherine Fahim, Boualem Mensour, Emmanuel Sti. Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study. Social neuroscience. vol 2. issue 2. 2008-12-12. PMID:18633810. schizophrenia patients (dsm-iv criteria) were divided into two groups: patients with (n=12) and without (n=11) substance use (alcohol and/or cannabis). 2008-12-12 2023-08-12 Not clear
Chris Hollis, Madeleine J Groom, Debasis Das, Tim Calton, Alan T Bates, Hayley K Andrews, Georgina M Jackson, Peter F Liddl. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD). Schizophrenia research. vol 105. issue 1-3. 2008-12-11. PMID:18768298. different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (adhd). 2008-12-11 2023-08-12 Not clear
Chris Hollis, Madeleine J Groom, Debasis Das, Tim Calton, Alan T Bates, Hayley K Andrews, Georgina M Jackson, Peter F Liddl. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD). Schizophrenia research. vol 105. issue 1-3. 2008-12-11. PMID:18768298. controversy exists regarding whether young people at risk for schizophrenia are at increased risk of adverse mental effects of cannabis use. 2008-12-11 2023-08-12 Not clear
Daniele Fabio Zullino, Lakshmi Waber, Yasser Khazaa. Cannabis and the course of schizophrenia. The American journal of psychiatry. vol 165. issue 10. 2008-11-18. PMID:18829891. cannabis and the course of schizophrenia. 2008-11-18 2023-08-12 Not clear
William F Costai. The effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives. International journal of mental health nursing. vol 17. issue 4. 2008-10-24. PMID:18666905. the effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives. 2008-10-24 2023-08-12 human
William F Costai. The effects of cannabis abuse on the symptoms of schizophrenia: patient perspectives. International journal of mental health nursing. vol 17. issue 4. 2008-10-24. PMID:18666905. this study explored explanatory models used by individuals with schizophrenia in relation to continuing cannabis abuse. 2008-10-24 2023-08-12 human
I Mata, J M Rodríguez-Sánchez, J M Pelayo-Terán, R Pérez-Iglesias, C González-Blanch, M Ramírez-Bonilla, O Martínez-García, J L Vázquez-Barquero, B Crespo-Facorr. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis. Psychological medicine. vol 38. issue 9. 2008-10-20. PMID:18005495. cannabis use appears to be a risk factor for schizophrenia. 2008-10-20 2023-08-12 Not clear
W Veling, J P Mackenbach, J van Os, H W Hoe. Cannabis use and genetic predisposition for schizophrenia: a case-control study. Psychological medicine. vol 38. issue 9. 2008-10-20. PMID:18485264. cannabis use and genetic predisposition for schizophrenia: a case-control study. 2008-10-20 2023-08-12 Not clear